ValiRx plc (LON:VAL – Get Free Report)’s share price dropped 9.5% during trading on Tuesday . The company traded as low as GBX 0.50 ($0.01) and last traded at GBX 0.50 ($0.01). Approximately 1,184,451 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 5,399,287 shares. The stock had previously closed at GBX 0.55 ($0.01).
ValiRx Price Performance
The business has a 50 day simple moving average of GBX 0.52 and a 200-day simple moving average of GBX 0.74. The company has a market capitalization of £1.89 million, a P/E ratio of -0.34 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Read More
- Five stocks we like better than ValiRx
- Dividend Capture Strategy: What You Need to Know
- Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
- What is a Bond Market Holiday? How to Invest and Trade
- Qualcomm: A Technical Deep-Dive Confirms the Worst
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
